ABTT34.SA
Abbott Laboratories
São PauloBRLEQUITY
DELAYED
Last price
49.75
■ 0.00 (0.00%)
MARKET · —
Price
Chart style
Interval
Intraday intervals only cover recent history. The site picks the finest interval the range allows.
Overlays
Session levels
Lower pane
Overlay another symbol
Both series are rebased to 0% at the left edge, so the lines show relative performance rather than price.
Tool
1D
—
H —
L —
Range —
Vol —
vs
Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw
Open
—
Prev close
49.75
Day high
49.75
Day low
49.75
Volume
—
Market cap
—
P/E (TTM)
—
52W range
33.50 – 61.82
Trailing performance
Returnvs SPY
1W
+2.81%
+3.9%
1M
+16.13%
+12.7%
3M
+37.51%
+35.0%
6M
+2.30%
-9.7%
YTD
-13.27%
-25.4%
1Y
-15.56%
-35.9%
3Y
+15.19%
-60.0%
5Y
—
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Free account
6 more panels on ABTT34.SA open with an account.
Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.
Fundamentals
Market cap—
Enterprise value—
Revenue (TTM)—
Gross profit—
EBITDA—
Net income—
EPS (TTM)—
Free cash flow—
Total cash—
Total debt—
Book value / share—
Shares outstanding—
Float—
Short % of float—
Dividend yield—
Beta (5Y)—
Valuation & profitability ratios
Trailing P/E—
Forward P/E—
PEG ratio—
Price / sales—
Price / book—
EV / revenue—
EV / EBITDA—
Gross margin—
Operating margin—
Profit margin—
Return on equity—
Return on assets—
Debt / equity—
Current ratio—
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Total revenue | $44.33B | $41.95B | $40.11B | $43.65B | +5.7% |
| Operating revenue | $44.33B | $41.95B | $40.11B | $43.65B | +5.7% |
| Cost of revenue | $19.32B | $18.71B | $17.98B | $19.14B | +3.3% |
| Gross profit | $25.01B | $23.24B | $22.13B | $24.51B | +7.6% |
| Research & development | $2.94B | $2.84B | $2.74B | $2.89B | +3.4% |
| Selling, general & admin | $12.33B | $11.70B | $10.95B | $11.25B | +5.4% |
| Total operating expense | $16.96B | $16.42B | $15.66B | $16.15B | +3.3% |
| Operating income | $8.05B | $6.83B | $6.48B | $8.36B | +18.0% |
| Net interest income | -$185.00M | -$215.00M | -$252.00M | -$375.00M | +14.0% |
| Pre-tax income | $8.47B | $7.01B | $6.66B | $8.31B | +20.7% |
| Tax provision | $1.94B | -$6.39B | $941.00M | $1.37B | +130.4% |
| Net income | $6.52B | $13.40B | $5.72B | $6.93B | -51.3% |
| Net income to common | $6.52B | $13.40B | $5.72B | $6.93B | -51.3% |
| Basic EPS | 0.31 | 0.64 | 0.28 | 0.33 | -51.5% |
| Diluted EPS | 0.31 | 0.64 | 0.27 | 0.33 | -51.3% |
| EBIT | $8.96B | $7.57B | $7.30B | $8.86B | +18.3% |
| EBITDA | $12.07B | $10.79B | $10.54B | $12.13B | +11.9% |
| Basic shares | 20.84B | 20.78B | 20.81B | 20.85B | +0.3% |
| Diluted shares | 20.99B | 20.98B | 20.99B | 21.17B | +0.1% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Cash & equivalents | $8.52B | $7.62B | $6.90B | $9.88B | +11.9% |
| Cash & short-term investments | $8.94B | $7.97B | $7.28B | $10.17B | +12.2% |
| Accounts receivable | $7.93B | $6.92B | $6.57B | $6.22B | +14.5% |
| Inventory | $6.49B | $6.19B | $6.57B | $6.17B | +4.7% |
| Total current assets | $26.00B | $23.66B | $22.67B | $25.22B | +9.9% |
| Property, plant & equipment | $11.82B | $10.66B | $10.15B | $9.16B | +10.9% |
| Goodwill & intangibles | $29.56B | $29.75B | $32.49B | $33.25B | -0.7% |
| Total assets | $86.71B | $81.41B | $73.21B | $74.44B | +6.5% |
| Total current liabilities | $16.50B | $14.16B | $13.84B | $15.49B | +16.5% |
| Current debt | $3.03B | $1.50B | $1.08B | $2.25B | +102.2% |
| Long-term debt | $9.90B | $12.63B | $13.60B | $14.52B | -21.6% |
| Total debt | $13.86B | $15.02B | $15.63B | $17.72B | -7.7% |
| Total liabilities | $33.94B | $33.51B | $34.39B | $37.53B | +1.3% |
| Retained earnings | $49.78B | $47.26B | $37.55B | $35.26B | +5.3% |
| Shareholder equity | $52.13B | $47.66B | $38.60B | $36.69B | +9.4% |
| Working capital | $9.50B | $9.50B | $8.83B | $9.73B | +0.0% |
| Net tangible assets | $22.57B | $17.91B | $6.11B | $3.43B | +26.0% |
| Shares issued | 2.00B | 1.99B | 1.99B | 1.99B | +0.3% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Net income | $6.52B | $13.40B | $5.72B | $6.93B | -51.3% |
| Depreciation & amortisation | $3.12B | $3.22B | $3.24B | $3.27B | -3.2% |
| Stock-based compensation | $664.00M | $673.00M | $644.00M | $685.00M | -1.3% |
| Change in working capital | -$803.00M | -$9.22B | -$2.48B | -$1.52B | +91.3% |
| Operating cash flow | $9.57B | $8.56B | $7.26B | $9.58B | +11.8% |
| Capital expenditure | -$2.17B | -$2.21B | -$2.20B | -$1.78B | +1.6% |
| Investing cash flow | -$2.42B | -$2.34B | -$3.13B | -$1.74B | -3.6% |
| Share buybacks | -$893.00M | -$1.29B | -$1.23B | -$3.79B | +31.0% |
| Dividends paid | -$4.12B | -$3.84B | -$3.56B | -$3.31B | -7.3% |
| Financing cash flow | -$6.31B | -$5.40B | -$7.09B | -$7.64B | -16.7% |
| Free cash flow | $7.39B | $6.35B | $5.06B | $7.80B | +16.4% |
| End cash position | $8.52B | $7.62B | $6.90B | $9.88B | +11.9% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | YoY |
|---|---|---|---|---|---|---|---|
| Total revenue | — | $11.16B | $11.46B | $11.37B | $11.14B | $10.36B | — |
| Operating revenue | — | $11.16B | $11.46B | $11.37B | $11.14B | $10.36B | — |
| Cost of revenue | — | $4.89B | $4.92B | $5.08B | $4.85B | $4.47B | — |
| Gross profit | — | $6.27B | $6.54B | $6.29B | $6.29B | $5.89B | — |
| Research & development | — | $767.00M | $735.00M | $766.00M | $725.00M | $716.00M | — |
| Selling, general & admin | — | $3.74B | $3.13B | $3.05B | $3.09B | $3.06B | — |
| Total operating expense | — | $4.93B | $4.29B | $4.24B | $4.24B | $4.20B | — |
| Operating income | — | $1.34B | $2.25B | $2.06B | $2.05B | $1.69B | — |
| Net interest income | — | -$68.00M | -$42.00M | -$44.00M | -$50.00M | -$49.00M | — |
| Pre-tax income | — | $1.45B | $2.36B | $2.18B | $2.15B | $1.78B | — |
| Tax provision | — | $372.00M | $582.00M | $536.00M | $371.00M | $453.00M | — |
| Net income | — | $1.08B | $1.78B | $1.64B | $1.78B | $1.32B | — |
| Net income to common | — | $1.08B | $1.78B | $1.64B | $1.78B | $1.32B | — |
| Basic EPS | 0.04 | 0.05 | 0.09 | 0.08 | 0.09 | — | -14.5% |
| Diluted EPS | 0.04 | 0.05 | 0.08 | — | 0.08 | 0.06 | -13.1% |
| EBIT | — | $1.62B | $2.48B | $2.30B | $2.27B | $1.91B | — |
| EBITDA | — | $2.43B | $3.27B | $3.09B | $3.05B | $2.67B | — |
| Basic shares | 20.89B | 20.91B | 20.84B | 20.87B | 20.89B | — | -0.1% |
| Diluted shares | 20.92B | 20.96B | 20.96B | 20.99B | 21.01B | — | -0.2% |
| Line item | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | YoY |
|---|---|---|---|---|---|---|
| Cash & equivalents | $6.80B | $8.52B | $7.51B | $6.95B | $6.53B | -20.2% |
| Cash & short-term investments | $7.29B | $8.94B | $7.73B | $7.28B | $6.84B | -18.4% |
| Accounts receivable | $8.21B | $7.93B | $8.14B | $7.97B | $7.33B | +3.5% |
| Inventory | $6.99B | $6.49B | $6.71B | $6.95B | $6.64B | +7.7% |
| Total current assets | $25.51B | $26.00B | $24.84B | $24.47B | $23.15B | -1.9% |
| Property, plant & equipment | $12.38B | $11.82B | $11.50B | $11.39B | $10.93B | +4.7% |
| Goodwill & intangibles | $53.10B | $29.56B | $29.57B | $29.87B | $29.62B | +79.6% |
| Total assets | $110.43B | $86.71B | $84.18B | $84.00B | $81.45B | +27.3% |
| Total current liabilities | $18.38B | $16.50B | $14.58B | $13.44B | $13.00B | +11.4% |
| Current debt | $4.41B | $3.03B | $1.34B | $507.00M | $506.00M | +45.4% |
| Long-term debt | $29.64B | $9.90B | $11.60B | $12.93B | $12.74B | +199.5% |
| Total debt | $34.05B | $13.86B | $12.94B | $13.44B | $13.24B | +145.6% |
| Total liabilities | $57.73B | $33.94B | $32.92B | $33.17B | $32.38B | +70.1% |
| Retained earnings | $49.96B | $49.78B | $49.10B | $48.47B | $47.72B | +0.4% |
| Shareholder equity | $52.06B | $52.13B | $50.95B | $50.56B | $48.81B | -0.1% |
| Working capital | $7.13B | $9.50B | $10.26B | $11.03B | $10.15B | -24.9% |
| Net tangible assets | -$1.03B | $22.57B | $21.39B | $20.69B | $19.19B | -104.6% |
| Shares issued | 2.00B | 2.00B | 2.00B | 2.00B | 2.00B | +0.1% |
| Line item | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | YoY |
|---|---|---|---|---|---|---|
| Net income | $1.08B | $1.78B | $1.64B | $1.78B | $1.32B | -39.4% |
| Depreciation & amortisation | $803.00M | $792.00M | $791.00M | $777.00M | $756.00M | +1.4% |
| Stock-based compensation | $317.00M | $113.00M | $120.00M | $142.00M | $289.00M | +180.5% |
| Change in working capital | -$462.00M | $110.00M | $11.00M | -$407.00M | -$517.00M | -520.0% |
| Operating cash flow | $1.31B | $3.31B | $2.79B | $2.05B | $1.42B | -60.3% |
| Capital expenditure | -$399.00M | -$689.00M | -$496.00M | -$502.00M | -$484.00M | +42.1% |
| Investing cash flow | -$20.32B | -$913.00M | -$457.00M | -$582.00M | -$470.00M | -2,126.1% |
| Share buybacks | -$180.00M | -$302.00M | -$305.00M | -$6.00M | -$280.00M | +40.4% |
| Dividends paid | -$1.10B | -$1.03B | -$1.03B | -$1.03B | -$1.03B | -6.6% |
| Financing cash flow | $17.31B | -$1.40B | -$1.76B | -$1.10B | -$2.06B | +1,339.3% |
| Free cash flow | $916.00M | $2.63B | $2.29B | $1.54B | $933.00M | -65.1% |
| End cash position | $6.80B | $8.52B | $7.51B | $6.95B | $6.53B | -20.2% |
Analyst targets & ownership
Mean target—
High target—
Low target—
Implied upside—
Analyst count—
Consensus—
Strong buy / Buy— / —
Hold—
Sell / Strong sell— / —
Held by insiders—
Held by institutions—
Institutions holding—
Price targets, consensus spread, insider and institutional ownership.
Moving averages & technicals
SMA 10
48.21
+3.19% from price
SMA 20
46.69
+6.55% from price
SMA 50
42.81
+16.21% from price
SMA 100
40.61
+22.52% from price
SMA 200
46.54
+6.90% from price
EMA 12
47.91
+3.84% from price
EMA 26
45.98
+8.21% from price
EMA 50
43.99
+13.10% from price
RSI (14)
73.5
Overbought
MACD (12,26,9)
1.93
Hist 0.16
ATR (14)
0.80
1.60% of price
Realised vol 30D
41.2%
Annualised
Bollinger upper
50.19
20, 2σ
Bollinger lower
43.19
20, 2σ
50 / 200 cross
Death
42.81 vs 46.54
Trend bias
Above 200
+6.90%
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Risk profile
Beta vs SPY
-0.35
Less volatile than market
Correlation to SPY
-0.15
Largely independent
Realised vol 30D
41.2%
Annualised
Market vol 1Y
12.8%
SPY, annualised
Max drawdown 1Y
-45.0%
Peak to trough
Max drawdown 5Y
-50.2%
Peak to trough
ATR 14
0.80
1.60% of price
Beta (reported)
—
5Y monthly, from filing
Headlines
Unifor, GM Canada reach tentative labour deal
Just Auto · 2m ago
Coca Cola Insider Sold Shares Worth $10,126,453, According to a Recent SEC Filing
MT Newswires · 3m ago
Market Chatter: Trump Planning to Impose 7.5% Overcapacity Tariffs on China
MT Newswires · 4m ago
Bill Ackman's Pershing Square is reportedly taking a $1.12 billion stake in Visa.
Yahoo Finance · 5m ago
Value per Security
Business Wire · 6m ago
Update: Chevron Signs Production Sharing Deal With Libya's National Oil Corporation
MT Newswires · 7m ago
Roche’s pTau217 single-biomarker Alzheimer’s blood test lands FDA approval
Medical Device Network · 8m ago
BJ's Wholesale Club's Fiscal Q2 Results Demonstrate Business Model's Relevance, UBS Says
MT Newswires · 10m ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.